These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10369711)

  • 1. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis.
    Uhl W; Büchler MW; Malfertheiner P; Beger HG; Adler G; Gaus W
    Gut; 1999 Jul; 45(1):97-104. PubMed ID: 10369711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders.
    Friess H; Büchler MW
    Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of octreotide and somatostatin in acute and chronic pancreatitis.
    Uhl W; Anghelacopoulos SE; Friess H; Büchler MW
    Digestion; 1999; 60 Suppl 2():23-31. PubMed ID: 10207228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure.
    Fiedler F; Jauernig G; Keim V; Richter A; Bender HJ
    Intensive Care Med; 1996 Sep; 22(9):909-15. PubMed ID: 8905425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
    Paran H; Neufeld D; Mayo A; Shwartz I; Singer P; Kaplan O; Skornik Y; Klausner J; Freund U
    J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis.
    McKay C; Baxter J; Imrie C
    Int J Pancreatol; 1997 Feb; 21(1):13-9. PubMed ID: 9127169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of severe acute pancreatitis with octreotide in obese patients: a prospective multi-center randomized controlled trial.
    Yang F; Wu H; Li Y; Li Z; Wang C; Yang J; Hu B; Huang Z; Ji R; Zhan X; Xie H; Wang L; Zhang M; Tang C
    Pancreas; 2012 Nov; 41(8):1206-12. PubMed ID: 23086244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.
    Büchler MW; Binder M; Friess H
    Gut; 1994; 35(3 Suppl):S15-9. PubMed ID: 7911442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.
    Caroli A; Perico N; Perna A; Antiga L; Brambilla P; Pisani A; Visciano B; Imbriaco M; Messa P; Cerutti R; Dugo M; Cancian L; Buongiorno E; De Pascalis A; Gaspari F; Carrara F; Rubis N; Prandini S; Remuzzi A; Remuzzi G; Ruggenenti P;
    Lancet; 2013 Nov; 382(9903):1485-95. PubMed ID: 23972263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial.
    Testoni PA; Bagnolo F; Andriulli A; Bernasconi G; Crotta S; Lella F; Lomazzi A; Minoli G; Natale C; Prada A; Toti GL; Zambelli A
    Aliment Pharmacol Ther; 2001 Jul; 15(7):965-72. PubMed ID: 11421871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1).
    van Bergeijk JD; Wilson JH; Nielsen OH; von Tirpitz C; Karvonen AL; Lygren I; Rädler A; Waldum HL; Mulder CJ; Friis S; Tefera S; Hoogkamer JF;
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):243-8. PubMed ID: 11953688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of octreotide on acute pancreatitis of varying severity in rats.
    Küçüktülü U; Alhan E; Erçin C; Cinel A; Calik A
    Eur J Surg; 1999 Sep; 165(9):891-6. PubMed ID: 10533767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
    Manolakopoulos S; Avgerinos A; Vlachogiannakos J; Armonis A; Viazis N; Papadimitriou N; Mathou N; Stefanidis G; Rekoumis G; Vienna E; Tzourmakliotis D; Raptis SA
    Gastrointest Endosc; 2002 Apr; 55(4):470-5. PubMed ID: 11923756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severity.
    Nikou GC; Arnaoutis TP; Giamarellos-Bourboulis EJ; Samolada O; Vafiadis-Zouboulis I; Katsilambros N; Arvanitakis C
    Hepatogastroenterology; 2001; 48(42):1754-7. PubMed ID: 11813617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
    Abid S; Jafri W; Hamid S; Salih M; Azam Z; Mumtaz K; Shah HA; Abbas Z
    Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
    Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
    Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide treatment in patients with severe acute pancreatitis.
    Paran H; Mayo A; Paran D; Neufeld D; Shwartz I; Zissin R; Singer P; Kaplan O; Skornik Y; Freund U
    Dig Dis Sci; 2000 Nov; 45(11):2247-51. PubMed ID: 11215748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.